Omeros reports full recovery from severe Covid-19 in six-patient study
The company said all the six patients, who needed mechanical ventilation before treatment, recovered and were discharged from hospital
The ultrastructural morphology exhibited by the 2019 Novel Coronavirus, which was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, is seen in an illustration released by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, US January 29, 2020/Reuters
Omeros Corp on Monday reported positive results from a six-patient study of its investigational treatment for Acute Respiratory Distress Syndrome caused by Covid-19.
The company said all the six patients, who needed mechanical ventilation before treatment, recovered and were discharged from hospital.
A manuscript detailing the results of the study has been accepted for publication in the peer-reviewed journal Immunobiology, Omeros said.
Keep updated, follow The Business Standard's Google news channel
Shares of the company soared 44 percent to $20.25 in premarket trading.
